Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects
Clinical trial NCT05844293 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05844293
- Sponsor
- Sirnaomics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2027-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.